vendredi 19 juin 2015

Onco Actu du 19 juin 2015

1. Biologie

‘Turning off’ bowel cancer – as easy as APC? [Cancer Research UK]

TCGA study of genetic drivers of melanoma [National Cancer Institute]

3.1 Tabac

Smoking causes half of all deaths in 12 different cancers [NHS Choices]

3.3 Prévention - Vaccins

EU approval for new Sanofi, Merck vaccine [Pharmafile]

5.2 Pharma

GlaxoSmithKline takes another big swing at cancer drug R&D [FierceBiotech]

French biotechs eye U.S. for investment, markets [Yahoo Finance]

Results From Phase 3 Trial Show Vectibix® (Panitumumab) Improves Overall Survival In Chemorefractory Wild-Type KRAS Metastatic Colorectal Cancer Versus Best Supportive Care [Amgen]

Amgen's cancer drug meets main goal in late-stage study [Reuters]

5.2.3 Pharma - économie

Most Americans say Drug Costs are Unreasonable and They Blame Pharma [Wall Street Journal]

Disease-Specific Allocations: The Past Decade Of Venture, IPOs, And Deal-making [LifeSciVC]

5.4 Traitements - Economie

The NHS ‘bottleneck’ for new cancer drugs [The Institute of Cancer Research]

ASCO Plans to Release Conceptual Value Framework to Assess the Value of New Cancer Treatment Options [ASCO]

NICE seeks more information on treatment for adults with leukaemia [NICE]

Sloan Kettering Drug Abacus - An interactive exploration of drug pricing [MSKCC]

How Much Should Cancer Drugs Cost? [Wall Street Journal]

6.11 Patients

Google search vs doctor diagnosis – always an imperfect balance [The Guardian]

Op-Ed Contributor: Clinical Trials Need Cancer Patients [NY Times]

6.6 Publications

2014 Journal Impact Factors [The Scholarly Kitchen]